|
We asked 40 pharma professionals, Where do you think your company should
be investing to increase profitability?
| New regions |
17% |
| New therapeutic areas |
33% |
| New technology |
8% |
| Outsourcing |
10% |
| Sales & marketing |
8% |
| In-house expertise |
24% |
 |
|
|
|
|
|
|
|
10 December, 2013
|
|
|
Will Pharma CEOs Warm to Social Media in 2014?
Depending who you listen to, as many as seven out of 10 CEOs are still cold on social media. But with a plethora of new research on social media’s strategic usefulness, Peter Houston wonders if that frostiness will thaw in 2014 ...Read more |
Russian Innovation: A Higher Mark
The pursuit of excellence in biopharmaceutical innovation in Russia has never had a sponsor—until now. Prix Galien International, a global network of Nobel laureates in medicines, established its 18th country beachhead in Moscow earlier this year, culminating in a historic first: an awards dinner to recognize the best in new drug research as well as innovation in biotechnology and pharmaceutical products ... Read more
|
Pharma and Biotech: Strategic, M&A, and Financial Trends 2013
Young & Partners’ "Pharma and Biotech Strategic, M&A, and Financial Trends Report" covers the first three quarters of 2013 and the outlook for 2014. Here, Peter Young highlights the external factors that have had an enormous incremental effect on the trends in pharma and biotech this year and that will continue to have an impact going forward ... Read more
|
Pharm Exec Global Digest: Personalized Medicine Special
Personalized medicines: Are they worth it?; Pathology in the era of personalized medicine; Clinical trial data disclosure — has Europe bitten off more than it can chew?; China: recruiting amid the corruption fallout; And more! ... Read more
|
Video: Lilly Strategy — Timely, Valued Medicines to Patients
Dr Jan Lundberg, EVP science and technology and president Lilly Research Labs, Lilly & Co., sits down to discuss the company’s new approach to drug development and its Phase III pipeline ... Read more
|
|
| Sciformix |
 Product labeling– Increasing efficiency, enhancing quality, and delivering compliance
Pharmaceutical product labeling is a highly regulated and complex process. A product label is very specific in its content, with respect to safety data, adverse effects and compliance to country specific regulations.  Read more. |
|
|
|
|
|
|
|
|
